hyaluronidase-oysk
1 abstract
Abstract
Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk or pertuzumab, trastuzumab, and hyaluronidase-zzxf in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma (NRG-GY026).Org: The GOG Foundation, Inc., Women and Infants Hospital, Brown University, Spectrum Health Cancer Center, LSU Health School of Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences Yale University School of Medicine,